MCID: MYL003
MIFTS: 47

Myeloid Sarcoma

Categories: Rare diseases, Cancer diseases, Blood diseases, Immune diseases

Aliases & Classifications for Myeloid Sarcoma

MalaCards integrated aliases for Myeloid Sarcoma:

Name: Myeloid Sarcoma 12 50 56 14
Granulocytic Sarcoma 12 50 56 69
Extramedullary Myeloid Tumor 12 50 56
Chloroma 12 50 56
Sarcoma Granulocytic 52
Sarcoma, Myeloid 42

Characteristics:

Orphanet epidemiological data:

56
myeloid sarcoma
Inheritance: Not applicable; Age of onset: All ages;

Classifications:



External Ids:

Disease Ontology 12 DOID:8683
ICD10 33 C92.3 C92.30
ICD9CM 35 205.3
MeSH 42 D023981
NCIt 47 C3520 C35815
Orphanet 56 ORPHA86850
MESH via Orphanet 43 D023981
UMLS via Orphanet 70 C0152276
ICD10 via Orphanet 34 C92.3
UMLS 69 C0152276

Summaries for Myeloid Sarcoma

NIH Rare Diseases : 50 this condition doesn't have a summary yet. please see our page(s) on acute myeloid leukemia .

MalaCards based summary : Myeloid Sarcoma, also known as granulocytic sarcoma, is related to sarcoma and classic hodgkin lymphoma, lymphocyte-rich type. An important gene associated with Myeloid Sarcoma is MPO (Myeloperoxidase), and among its related pathways/superpathways are NF-kappaB Signaling and Transcriptional misregulation in cancer. The drugs Aldesleukin and Asparaginase have been mentioned in the context of this disorder. Affiliated tissues include myeloid, bone and bone marrow, and related phenotypes are Increased shRNA abundance (Z-score > 2) and hematopoietic system

Wikipedia : 72 A myeloid sarcoma (chloroma, granulocytic sarcoma,extramedullary myeloid tumor), is a solid tumor... more...

Related Diseases for Myeloid Sarcoma

Diseases related to Myeloid Sarcoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 123)
id Related Disease Score Top Affiliating Genes
1 sarcoma 10.8
2 classic hodgkin lymphoma, lymphocyte-rich type 10.6 FLT3 MPO
3 acute myeloid leukemia with recurrent genetic anomaly 10.6 FLT3 NPM1
4 gum cancer 10.5 MPO PTPRC
5 leukemia 10.5
6 congenital sucrase-isomaltase deficiency with starch intolerance 10.4 NPM1 PTPRC
7 childhood spinal cord tumor 10.4 DNTT PTPRC
8 pulmonary valve agenesis-tetralogy of fallot-absence of ductus arteriosus syndrome 10.4 FLT3 KIT
9 chronic intestinal vascular insufficiency 10.4 PAX5 PTPRC
10 myeloid leukemia 10.4
11 estrogen-receptor positive breast cancer 10.4 NPM1 PTPRC
12 thakker-donnai syndrome 10.3 ANPEP DNTT
13 malignant sertoli-leydig cell tumor 10.3 KIT PAX5
14 filamentary keratitis 10.3 KIT PTPRC
15 alopecia antibody deficiency 10.3 FLT3 KIT
16 pericoronitis 10.3 KIT PTPRC
17 fallopian tube squamous cell carcinoma 10.3 KIT PTPRC
18 cask-related intellectual disability 10.2 FLT3 KIT
19 brain stem infarction 10.2 KIT PTPRC
20 ovarian cystic teratoma 10.2 KIT PTPRC
21 bobble-head doll syndrome 10.2 NCAM1 NPM1
22 dense deposit disease 10.2 DNTT MPO PTPRC
23 glomus tumor 10.2 KIT NCAM1
24 ethmoid sinus schneiderian papilloma 10.2 NCAM1 PTPRC
25 dyserythropoietic anemia and thrombocytopenia 10.2 FLT3 KIT
26 encephalitozoonosis 10.2 KIT NCAM1
27 pancreatic agenesis 10.1 KIT NCAM1
28 angiomatous meningioma 10.1 NCAM1 PTPRC
29 endometrioid ovary carcinoma 10.1 DNTT NCAM1
30 villoglandular endometrial endometrioid adenocarcinoma 10.1 NCAM1 PAX5
31 prostate disease 10.1 KIT NCAM1
32 urethral villous adenoma 10.1 KIT NCAM1
33 acute myeloid leukemia with inv3(p21;q26.2) or t(3;3)(p21;q26.2) 10.1 FLT3 KIT NPM1
34 vaginal yolk sac tumor 10.1 KIT NCAM1
35 acute pre-b-cell lymphoblastic leukemia 10.1 FLT3 KIT NPM1
36 aorta atresia 10.1 NPM1 PAX5 PTPRC
37 peroxisome biogenesis disorder 7a 10.0 DNTT FLT3 KIT
38 carnitine-acylcarnitine translocase deficiency 10.0 NPM1 PAX5 PTPRC
39 myelodysplastic syndrome 10.0
40 caroli disease 10.0 KIT NCAM1
41 spindle cell thymoma 10.0 DNTT KIT PTPRC
42 chronic venous leg ulcers 10.0 FLT3 KIT
43 hydrarthrosis 10.0 KIT NCAM1
44 cervicitis 9.9
45 mediastinitis 9.9
46 lung clear cell-sugar-tumor 9.9 KIT NCAM1
47 acute kidney failure 9.9 DNTT KMT2A MPO
48 pseudomyxoma peritonei 9.9 ANPEP KIT MPO
49 prostatitis 9.8
50 radiculopathy 9.8

Graphical network of the top 20 diseases related to Myeloid Sarcoma:



Diseases related to Myeloid Sarcoma

Symptoms & Phenotypes for Myeloid Sarcoma

GenomeRNAi Phenotypes related to Myeloid Sarcoma according to GeneCards Suite gene sharing:

26
id Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased shRNA abundance (Z-score > 2) GR00366-A-100 10.06 MPO
2 Increased shRNA abundance (Z-score > 2) GR00366-A-102 10.06 DNTT KIT FLT3
3 Increased shRNA abundance (Z-score > 2) GR00366-A-115 10.06 FLT3
4 Increased shRNA abundance (Z-score > 2) GR00366-A-120 10.06 FLT3
5 Increased shRNA abundance (Z-score > 2) GR00366-A-121 10.06 FLT3
6 Increased shRNA abundance (Z-score > 2) GR00366-A-122 10.06 FLT3
7 Increased shRNA abundance (Z-score > 2) GR00366-A-123 10.06 FLT3 DNTT
8 Increased shRNA abundance (Z-score > 2) GR00366-A-126 10.06 MPO
9 Increased shRNA abundance (Z-score > 2) GR00366-A-138 10.06 DNTT
10 Increased shRNA abundance (Z-score > 2) GR00366-A-151 10.06 DNTT
11 Increased shRNA abundance (Z-score > 2) GR00366-A-152 10.06 KIT
12 Increased shRNA abundance (Z-score > 2) GR00366-A-157 10.06 KIT MPO DNTT
13 Increased shRNA abundance (Z-score > 2) GR00366-A-16 10.06 DNTT
14 Increased shRNA abundance (Z-score > 2) GR00366-A-163 10.06 FLT3
15 Increased shRNA abundance (Z-score > 2) GR00366-A-170 10.06 KIT
16 Increased shRNA abundance (Z-score > 2) GR00366-A-176 10.06 MPO
17 Increased shRNA abundance (Z-score > 2) GR00366-A-182 10.06 DNTT
18 Increased shRNA abundance (Z-score > 2) GR00366-A-186 10.06 MPO
19 Increased shRNA abundance (Z-score > 2) GR00366-A-197 10.06 DNTT
20 Increased shRNA abundance (Z-score > 2) GR00366-A-25 10.06 FLT3
21 Increased shRNA abundance (Z-score > 2) GR00366-A-29 10.06 MPO
22 Increased shRNA abundance (Z-score > 2) GR00366-A-30 10.06 KIT
23 Increased shRNA abundance (Z-score > 2) GR00366-A-36 10.06 MPO
24 Increased shRNA abundance (Z-score > 2) GR00366-A-42 10.06 KIT
25 Increased shRNA abundance (Z-score > 2) GR00366-A-57 10.06 MPO
26 Increased shRNA abundance (Z-score > 2) GR00366-A-7 10.06 MPO
27 Increased shRNA abundance (Z-score > 2) GR00366-A-70 10.06 FLT3 MPO
28 Increased shRNA abundance (Z-score > 2) GR00366-A-73 10.06 DNTT
29 Increased shRNA abundance (Z-score > 2) GR00366-A-85 10.06 KIT
30 Increased shRNA abundance (Z-score > 2) GR00366-A-9 10.06 KIT
31 Increased shRNA abundance (Z-score > 2) GR00366-A-99 10.06 KIT

MGI Mouse Phenotypes related to Myeloid Sarcoma:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 9.91 KMT2A MPO NPM1 PAX5 PTPRC ANPEP
2 cellular MP:0005384 9.87 KIT KMT2A NCAM1 NPM1 PAX5 PTPRC
3 immune system MP:0005387 9.81 ANPEP DNTT FLT3 KIT KMT2A MPO
4 mortality/aging MP:0010768 9.56 FLT3 KIT KMT2A MPO NCAM1 NPM1
5 neoplasm MP:0002006 9.1 FLT3 KIT KMT2A NPM1 PAX5 PTPRC

Drugs & Therapeutics for Myeloid Sarcoma

Drugs for Myeloid Sarcoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 135)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Aldesleukin Approved Phase 3,Phase 2,Phase 1 85898-30-2, 110942-02-4
2
Asparaginase Approved Phase 3 9015-68-3
3
Busulfan Approved, Investigational Phase 3,Phase 2 55-98-1 2478
4
Cyclophosphamide Approved, Investigational Phase 3,Phase 1,Phase 2 50-18-0, 6055-19-2 2907
5
Cytarabine Approved, Investigational Phase 3,Phase 2 147-94-4 6253
6
Daunorubicin Approved Phase 3 20830-81-3 30323
7
Dexamethasone Approved, Investigational, Vet_approved Phase 3 50-02-2 5743
8
Etoposide Approved Phase 3 33419-42-0 36462
9
Fludarabine Approved Phase 3,Phase 2,Phase 1 21679-14-1, 75607-67-9 30751
10
Hydrocortisone Approved, Vet_approved Phase 3 50-23-7 5754 657311
11
Idarubicin Approved Phase 3 58957-92-9 42890
12
Lenograstim Approved Phase 3,Phase 2,Phase 1 135968-09-1
13
Methotrexate Approved Phase 3 1959-05-2, 59-05-2 126941
14
Thioguanine Approved Phase 3 154-42-7 2723601
15
Mitoxantrone Approved, Investigational Phase 3,Phase 2 65271-80-9 4212
16
Bortezomib Approved, Investigational Phase 3 179324-69-7 387447 93860
17
Pegaspargase Approved, Investigational Phase 3 130167-69-0
18
Sorafenib Approved, Investigational Phase 3 284461-73-0 216239 406563
19
Folic Acid Approved, Nutraceutical, Vet_approved Phase 3 59-30-3 6037
20
leucovorin Approved, Nutraceutical Phase 3 58-05-9 143 6006
21
Niacin Approved, Investigational, Nutraceutical Phase 3 59-67-6 938
22
Nicotinamide Approved, Nutraceutical Phase 3 98-92-0 936
23
Butyric Acid Experimental Phase 3 107-92-6 264
24 Alkylating Agents Phase 3,Phase 2,Phase 1
25 Analgesics Phase 3,Phase 2,Phase 1
26 Analgesics, Non-Narcotic Phase 3,Phase 2,Phase 1
27 Anti-Bacterial Agents Phase 3,Phase 2
28 Antibiotics, Antitubercular Phase 3,Phase 2
29 Antiemetics Phase 3
30 Anti-HIV Agents Phase 3,Phase 2
31 Anti-Infective Agents Phase 3,Phase 2,Phase 1
32 Anti-Inflammatory Agents Phase 3
33 Antimetabolites Phase 3,Phase 2,Phase 1
34 Antimetabolites, Antineoplastic Phase 3,Phase 2,Phase 1
35 Antineoplastic Agents, Hormonal Phase 3
36 Antineoplastic Agents, Phytogenic Phase 3
37 Anti-Retroviral Agents Phase 3,Phase 2
38 Antirheumatic Agents Phase 3,Phase 1,Phase 2
39 Antiviral Agents Phase 3,Phase 2,Phase 1
40 Autonomic Agents Phase 3
41 BB 1101 Phase 3
42 Cortisol succinate Phase 3
43 Dermatologic Agents Phase 3
44 Dexamethasone acetate Phase 3 1177-87-3
45 Etoposide phosphate Phase 3
46 Folic Acid Antagonists Phase 3
47 Gastrointestinal Agents Phase 3
48 glucocorticoids Phase 3
49 Hormone Antagonists Phase 3
50 Hormones Phase 3

Interventional clinical trials:

(show all 35)

id Name Status NCT ID Phase Drugs
1 Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome Completed NCT00002798 Phase 3 asparaginase;daunorubicin hydrochloride;fludarabine phosphate;therapeutic hydrocortisone;cytarabine;idarubicin;dexamethasone;thioguanine;etoposide;methotrexate;cyclophosphamide;busulfan
2 Quizartinib With Standard of Care Chemotherapy and as Maintenance Therapy in Patients With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia (AML) Recruiting NCT02668653 Phase 3 Chemotherapy;Quizartinib;Placebo
3 Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Active, not recruiting NCT01371981 Phase 3 Asparaginase;Bortezomib;Cytarabine;Daunorubicin Hydrochloride;Etoposide;Mitoxantrone Hydrochloride;Sorafenib Tosylate
4 Study of NRX 195183 Therapy for Patients With Relapsed or Refractory Acute Promyelocytic Leukemia Unknown status NCT00675870 Phase 2 NRX 195183 Soft Gelatin Capsule
5 Evaluation of Side Effects and Relative Activity of Two Chemotherapy Regimens in the Treatment Soft Tissue Sarcoma Completed NCT00189137 Phase 2 ifosfamide and doxorubicin vs gemcitabine and docetaxel
6 Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia Completed NCT01154816 Phase 2 Alisertib
7 Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect Completed NCT00003425 Phase 1, Phase 2 amifostine trihydrate;cyclophosphamide;melphalan
8 CIP-613, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Granulocytic Sarcoma Recruiting NCT02484391 Phase 2 6,8-Bis(benzylthio)octanoic Acid;Cytarabine;Mitoxantrone Hydrochloride
9 Vosaroxin and Infusional Cytarabine in Treating Patients With Untreated Acute Myeloid Leukemia Recruiting NCT02658487 Phase 2 Cytarabine;Vosaroxin
10 Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation Recruiting NCT02790515 Phase 2 Anti-thymocyte globulin (rabbit);Blinatumomab;Cyclophosphamide;Fludarabine;G-CSF;Melphalan;Mesna;Rituximab;Tacrolimus;Thiotepa;Sirolimus
11 PLX3397 in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) Recruiting NCT02390752 Phase 1, Phase 2 PLX3397
12 Repeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior Transplantation Terminated NCT02259348 Phase 2 Cyclophosphamide;Fludarabine;Melphalan;Thiotepa;Rituximab
13 T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant Terminated NCT01621477 Phase 2 clofarabine;cytarabine;busulfan;Plerixafor;cyclophosphamide;antithymocyte globulin (rabbit);Tacrolimus;mycophenolate mofetil
14 Pilot Study of Expanded, Donor Natural Killer Cell Infusions for Refractory Non-B Lineage Hematologic Malignancies and Solid Tumors Completed NCT00640796 Phase 1 Chemotherapy
15 Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors Completed NCT00093821 Phase 1 tanespimycin
16 An Extension Study of RO5045337 in Participants Participating in Previous Roche-sponsored Cancer Studies Completed NCT01677780 Phase 1 RO5045337
17 Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy Completed NCT00030108 Phase 1 ixabepilone
18 Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors Recruiting NCT02390843 Phase 1 Simvastatin;Cyclophosphamide;Topotecan;Myeloid growth factor
19 Study of BLU-285 in Patients With Advanced Systemic Mastocytosis (advSM) and Relapsed or Refractory Myeloid Malignancies Recruiting NCT02561988 Phase 1 BLU-285
20 A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies Recruiting NCT02498665 Phase 1 DSP-7888 Dosing Emulsion
21 Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies Recruiting NCT02223052 Phase 1 CC-486;Vidaza
22 TCRαβ+/CD19+ Depleted Haploidentical HSCT + Zoledronate Recruiting NCT02508038 Phase 1 Zoledronate
23 Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803 Not yet recruiting NCT02890758 Phase 1
24 Dendritic Cell Vaccine With or Without Gemcitabine Pre-Treatment for Adults and Children With Sarcoma Suspended NCT01803152 Phase 1 Gemcitabine;Imiquimod
25 PET-CT in AML for Detection of Extramedullary AML Manifestations Completed NCT01278069
26 Genetic Study of Children With Soft Tissue Sarcoma or Rhabdomyosarcoma Completed NCT00003793
27 The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients Completed NCT00726934
28 Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer Completed NCT00002485
29 Metabolic Syndrome in Childhood Cancer Survivors Completed NCT00920738
30 Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer Recruiting NCT03154190
31 Collecting and Storing Tissue From Young Patients With Cancer Recruiting NCT00898755
32 High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors Active, not recruiting NCT00536601 etoposide;cyclophosphamide;carmustine;melphalan;busulfan;carboplatin;thiotepa
33 Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor Active, not recruiting NCT00638898 busulfan;melphalan;topotecan hydrochloride
34 Early Enteral Tube Feedings in Children Receiving Chemo for AML/MDS & High Risk Solid Tumors Withdrawn NCT00624962
35 Acupuncture Point Stimulation for Treatment of Chemotherapy Nausea and Vomiting Withdrawn NCT01492569

Search NIH Clinical Center for Myeloid Sarcoma

Cochrane evidence based reviews: sarcoma, myeloid

Genetic Tests for Myeloid Sarcoma

Anatomical Context for Myeloid Sarcoma

MalaCards organs/tissues related to Myeloid Sarcoma:

39
Myeloid, Bone, Bone Marrow, T Cells, Breast, Nk Cells, Liver

Publications for Myeloid Sarcoma

Articles related to Myeloid Sarcoma:

(show top 50) (show all 325)
id Title Authors Year
1
Detection of prognostically relevant mutations and translocations in myeloid sarcoma by next generation sequencing. ( 28633614 )
2018
2
Successful second allogeneic stem cell transplantation in a patient with T-lymphoblastic leukemia (T-ALL) relapsed as myeloid sarcoma. ( 28451803 )
2017
3
Myeloid sarcoma causing airway obstruction. ( 28405080 )
2017
4
Clinical features and outcomes of extramedullary myeloid sarcoma in the United States: analysis using a national data set. ( 28841208 )
2017
5
An unusual type of myeloid sarcoma localization following myelofibrosis: A case report and literature review. ( 28794969 )
2017
6
Myeloid Sarcoma Presenting as Nasal and Orbital Mass: An Initial Manifestation of an Acute Myeloid Leukaemia. ( 28892915 )
2017
7
Prostate Mass as a First Manifestation of Myeloid Sarcoma in a Patient With an Occult Acute Myeloid Leukemia-A Case Report. ( 28627396 )
2017
8
Isolated Intracranial Myeloid Sarcoma Occurring as Relapse in Acute Myeloid Leukemia. ( 28694637 )
2017
9
Primary myeloid sarcoma of small bowel. ( 28596206 )
2017
10
Cardiac Myeloid Sarcoma: Review of Literature. ( 28511492 )
2017
11
Clinicoradiological characteristics, management and prognosis of primary myeloid sarcoma of the central nervous system: A report of four cases. ( 28927153 )
2017
12
Extensive ulcerated lesions in a patient with cutaneous myeloid sarcoma responded to twice-daily fludarabine and cytarabine regimen. ( 28624256 )
2017
13
Myeloid sarcoma identified on liquid-based cervical cytology samples: A report of two cases. ( 28569009 )
2017
14
Extramedullary leukaemia presenting as cardiac myeloid sarcoma. ( 28513107 )
2017
15
Myeloid sarcoma of the sigmoid colon: An unusual presentation of a rare condition. ( 28606757 )
2017
16
How Rare Is an Oral Presentation of Myeloid Sarcoma in the Infant? ( 28943463 )
2017
17
Successful 5-azacytidine treatment of myeloid sarcoma and leukemia cutis associated with myelodysplastic syndrome: A case report and literature review. ( 28885352 )
2017
18
Clinical characteristics, molecular profile and outcomes of myeloid sarcoma: a single institution experience over 13 years. ( 28574302 )
2017
19
Myeloid Sarcoma in a Patient with Myelodysplastic Syndrome Associated with del(5q-): Case Report and Literature Review. ( 28801374 )
2017
20
Invasive Fungal Infection in Acute Myeloid Leukemia Associated with Myeloid Sarcoma of the Sinonasal Cavity: A Rare Case. ( 28607903 )
2017
21
Do Not Forget the Glycophorin A: An Unusual Case of Myeloid Sarcoma. ( 26907661 )
2016
22
Cardiac Myeloid Sarcoma - Multimodality Radiologic Imaging Features and Pathologic Correlation. ( 27103046 )
2016
23
Spontaneous remission of aleukemic cutaneous myeloid sarcoma followed by crisis of acute monoblastic leukemia. ( 26661142 )
2016
24
Cytokeratin-type intermediate filaments in a gastric myeloid sarcoma: a diagnostic pitfall. ( 28092890 )
2016
25
Clinicopathological, Cytogenetic, and Prognostic Analysis of 131 Myeloid Sarcoma Patients. ( 27631510 )
2016
26
Myeloid sarcoma presenting as a colon polyp and harbinger of chronic myelogenous leukemia. ( 26989468 )
2016
27
Isolated myeloid sarcoma. ( 27560717 )
2016
28
Detection of clonal heterogeneity and targetable mutations in myeloid sarcoma by high-throughput sequencing. ( 27659839 )
2016
29
Myeloid sarcoma of submandibular salivary gland. ( 27489709 )
2016
30
Hepatic myeloid sarcoma diagnosed at autopsy: A case report. ( 27773146 )
2016
31
Myeloid Sarcoma of the Hepatobiliary System: A Case Series and Review of the Literature. ( 27007946 )
2016
32
Isolated spinal myeloid sarcoma with rapid progression. ( 26828010 )
2016
33
Bilateral Myeloid Sarcoma of Breast in a Young Male Occurring after 11 Years of Chronic Myeloid Leukemia Diagnosis: A Unique Pattern of Relapse. ( 27488267 )
2016
34
Orbital myeloid sarcoma: Rare presentation of AML. ( 27074545 )
2016
35
Isolated Uterine Myeloid Sarcoma Preceding the Diagnosis of Acute Myeloid Leukemia. ( 27376223 )
2016
36
A rare case of dorsal-cervical spine myeloid sarcoma detected on (18)F-FDG PET/CT scan. ( 27498227 )
2016
37
Primary Myeloid Sarcoma of the Small Intestine: Case Report and Literature Review. ( 27509642 )
2016
38
Bilateral orbital myeloid sarcoma preceding acute myeloid leukemia in an adult: a case report and review of the literature. ( 26846095 )
2016
39
Myeloid Sarcoma in an Eyelid That Developed during Chemotherapy for Acute Myeloid Leukemia. ( 26889156 )
2016
40
Myeloid sarcoma of the periprostatic tissue and prostate: Case report and review of literature. ( 27453659 )
2016
41
Myeloid Sarcoma Presenting as Low Back Pain in the Pediatric Emergency Department. ( 27395325 )
2016
42
Myeloid Sarcoma in the Orbit. ( 27977030 )
2016
43
Evidence for a role of decitabine in the treatment of myeloid sarcoma. ( 27817041 )
2016
44
Shoulder Myeloid Sarcoma: An Initial Presentation of CML Blast Crisis. ( 27408438 )
2016
45
Myeloid sarcoma derived from the gastrointestinal tract: A case report and review of the literature. ( 27313759 )
2016
46
Encapsulated relapsed flt3+AML (myeloid sarcoma) and hurthle cell adenoma presenting in composite: unlikely partners. ( 27643393 )
2016
47
The progression of CD56(+) myeloid sarcoma: A case report and literature review. ( 27123069 )
2016
48
Myeloid Sarcoma Of Vulva: A Short Update. ( 27408359 )
2016
49
Low back pain and femoral neuralgia revealing myeloid sarcoma with megakaryocytic differentiation. ( 26992956 )
2016
50
A Case of Myeloid Sarcoma of Intestine. ( 27646584 )
2016

Variations for Myeloid Sarcoma

Expression for Myeloid Sarcoma

Search GEO for disease gene expression data for Myeloid Sarcoma.

Pathways for Myeloid Sarcoma

GO Terms for Myeloid Sarcoma

Cellular components related to Myeloid Sarcoma according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 external side of plasma membrane GO:0009897 8.92 ANPEP KIT NCAM1 PTPRC

Biological processes related to Myeloid Sarcoma according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 visual learning GO:0008542 9.32 KIT KMT2A
2 T cell differentiation GO:0030217 9.26 KIT PTPRC
3 positive regulation of phosphatidylinositol 3-kinase activity GO:0043552 9.16 FLT3 KIT
4 embryonic hemopoiesis GO:0035162 8.96 KIT KMT2A
5 myeloid progenitor cell differentiation GO:0002318 8.62 FLT3 KIT

Sources for Myeloid Sarcoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....